Biomarker research can be influential across all phases of drug development, from drug discovery and preclinical evaluations to clinical development and post-marketing studies. Biomarkers are important tools for informed decision-making and can include everything from proteins, peptides, cells, ... Read more
In a recent Editorial Article, Dr. Erik Tillman, Principal Scientist at Akero Therapeutics, describes his company’s quest to find an effective treatment for non-alcoholic steatohepatitis and how the functional iLite assay-ready cells they use deliver robust, reproducible, and convenient ... Read more
To make the right decision you need as many facts as possible available. Scientists and drug developers are in a constant struggle to make many key decisions about their potential compound – Is it working? Is it safe? Does it have a clinical impact? Does it have a large enough clinical impact? Are ... Read more
Over the last decade, biologic therapeutic proteins have advanced the treatment of many diseases with therapeutic antibodies such as infliximab, adalimumab, rituximab, tocilizumab, golimumab, certolizumab pegol, just to mention a few. One limitation for the use of therapeutic antibodies is ... Read more
